NOTE F39 Associates and joint ventures
- Index
- 36 NOTE F36 Commitments to acquire property, plant, and equipment, and intangible assets
- 37 NOTE F37 Contingent liabilities
- 38 NOTE F38 Dividends proposed for distribution
- 39 NOTE F39 Associates and joint ventures
- 40 NOTE F40 Joint operations
- 41 NOTE F41 Non-controlling interests (continuing operations)
- 42 NOTE F42 Related parties
- 43 NOTE F43 Events after the reporting period
- 44 NOTE F44 List of companies included in the consolidation scope
The associates and joint ventures not classified as held for sale/discontinued operations are accounted for under the equity method of accounting.
In € million |
2017 |
2016 |
||||||||||
Associates |
Joint ventures |
Total |
Associates |
Joint ventures |
Total |
|||||||
Investments in associates and joint ventures |
23 |
443 |
466 |
24 |
473 |
497 |
||||||
Earnings from associates and joint ventures |
3 |
41 |
44 |
2 |
83 |
85 |
The tables below present the summary of the statement of financial position and income statement of the material associates and joint ventures as if they were proportionately consolidated.
Associates
In € million |
2017 |
2016 |
||
Statement of financial position |
||||
Non-current assets |
22 |
25 |
||
Current assets |
17 |
37 |
||
Cash and cash equivalents |
5 |
6 |
||
Non-current liabilities |
3 |
8 |
||
Non current financial debt |
2 |
5 |
||
Current liabilities |
14 |
31 |
||
Current financial debt |
4 |
6 |
||
Investments in associates |
23 |
24 |
||
Income statement |
||||
Sales |
34 |
93 |
||
Depreciation and amortization |
(1) |
(2) |
||
Interest on lendings and short term deposits |
1 |
|
||
Income taxes |
|
(1) |
||
Profit (loss) for the year from continuing operations |
2 |
3 |
||
Profit (loss) for the year |
2 |
3 |
||
Total comprehensive income |
1 |
3 |
||
Dividends received |
1 |
2 |
Joint ventures
In € million |
2017 |
|||||||||||||||
RusVinyl OOO |
Peroxidos do Brasil Ltda |
Solvay & CPC Barium Strontium |
Shandong Huatai Interox Chemical Co. Ltd |
Hindustan Gum & Chemicals Ltd |
EECO Holding and subsidiaries |
Cogeneration Rosignano |
Other |
|||||||||
Ownership interest |
50.0% |
69.4% |
75.0% |
50.0% |
50.0% |
33.3% |
25.4% |
|
||||||||
Operating Segment |
Performance Chemicals |
Performance Chemicals |
Advanced Materials |
Performance Chemicals |
Advanced Formulations |
Corporate & Business Services |
Corporate & Business Services |
|
||||||||
Statement of financial position |
||||||||||||||||
Non-current assets |
423 |
43 |
11 |
8 |
7 |
15 |
9 |
|
||||||||
Current assets |
45 |
48 |
42 |
4 |
154 |
16 |
3 |
|
||||||||
Cash and cash equivalents |
13 |
27 |
8 |
2 |
137 |
4 |
|
|
||||||||
Non-current liabilities |
226 |
6 |
12 |
|
4 |
10 |
|
|
||||||||
Long-term financial debt |
197 |
4 |
|
|
|
10 |
|
|
||||||||
Current liabilities |
55 |
20 |
13 |
4 |
9 |
18 |
7 |
|
||||||||
Short-term financial debt |
38 |
4 |
|
|
|
17 |
7 |
|
||||||||
Investments in joint ventures |
186 |
65 |
28 |
8 |
148 |
3 |
4 |
|
||||||||
Income statement |
||||||||||||||||
Sales |
171 |
75 |
75 |
11 |
42 |
5 |
|
|
||||||||
Depreciation and amortization |
(25) |
(3) |
(1) |
(1) |
(1) |
(1) |
|
|
||||||||
Cost of borrowings |
(21) |
|
|
|
|
(1) |
|
|
||||||||
Interest on lendings and short term deposits |
|
2 |
|
|
10 |
|
|
|
||||||||
Income taxes |
(1) |
(8) |
(3) |
|
(3) |
|
|
|
||||||||
Profit (loss) for the year from continuing operations |
4 |
19 |
9 |
1 |
7 |
|
|
2 |
||||||||
Profit (loss) for the year |
4 |
19 |
9 |
1 |
7 |
|
|
2 |
||||||||
Other comprehensive income |
(15) |
(11) |
(1) |
(1) |
(9) |
|
|
|
||||||||
Total comprehensive income |
(10) |
8 |
8 |
|
(2) |
|
|
2 |
||||||||
Dividends received |
|
9 |
6 |
(1) |
1 |
|
|
|
Other comprehensive income comprises mainly the currency translation differences.
In € million |
2016 |
|||||||||||
RusVinyl OOO |
Peroxidos do Brasil Ltda |
Solvay & CPC Barium Strontium |
Shandong Huatai Interox Chemical Co. Ltd |
Hindustan Gum & Chemicals Ltd |
Other |
|||||||
Ownership interest |
50.0% |
69.4% |
75.0% |
50.0% |
50.0% |
|
||||||
Operating Segment |
Performance Chemicals |
Performance Chemicals |
Advanced Materials |
Performance Chemicals |
Advanced Formulations |
|
||||||
Statement of financial position |
||||||||||||
Non-current assets |
476 |
38 |
12 |
10 |
8 |
17 |
||||||
Current assets |
42 |
61 |
39 |
2 |
157 |
44 |
||||||
Cash and cash equivalents |
11 |
36 |
5 |
|
147 |
8 |
||||||
Non-current liabilities |
252 |
7 |
12 |
|
1 |
11 |
||||||
Long-term financial debt |
224 |
4 |
|
|
|
10 |
||||||
Current liabilities |
71 |
27 |
13 |
3 |
11 |
27 |
||||||
Short-term financial debt |
47 |
8 |
|
|
|
15 |
||||||
Investments in joint ventures |
197 |
66 |
26 |
9 |
153 |
23 |
||||||
Income statement |
||||||||||||
Sales |
153 |
70 |
68 |
11 |
20 |
51 |
||||||
Depreciation and amortization |
(22) |
(3) |
(1) |
(1) |
(1) |
(1) |
||||||
Reversal of impairment |
19 |
|
|
|
|
|
||||||
Cost of borrowings |
(23) |
|
|
|
|
(1) |
||||||
Interest on lendings and short term deposits |
|
3 |
|
|
9 |
1 |
||||||
Income taxes |
(12) |
(9) |
(2) |
|
(3) |
(1) |
||||||
Profit (loss) for the year from continuing operations |
49 |
19 |
8 |
|
7 |
1 |
||||||
Profit (loss) for the year |
49 |
19 |
8 |
|
7 |
1 |
||||||
Other comprehensive income |
36 |
13 |
(2) |
|
1 |
4 |
||||||
Total comprehensive income |
85 |
32 |
6 |
|
8 |
5 |
||||||
Dividends received |
|
11 |
6 |
1 |
1 |
1 |
Other comprehensive income comprises mainly the currency translation differences.